retaglutide is the next gen (3rd) GLP-1 which is in phase 3 trials now. It is a triple antagonist (current are dual GLP-1/GIP). It adds glucagon, and apparently that comes with not only greatly increased weightloss, but also wicked sugar cravings.
These things do way way more than just appetite and craving suppression.
Interesting! how does that work though? I thought reduced sugar craving was part of how GLP-1s aid in weight loss as the paitent craves sugar less and thus eats less.
kion|3 months ago
These things do way way more than just appetite and craving suppression.
fragmede|3 months ago